Covered recipient · General Payments record
REX D CHANG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$229.04
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.04 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $54.72 | 2 |
| PFIZER INC. | $37.93 | 2 |
| Teva Pharmaceuticals USA, Inc. | $28.91 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.64 | 1 |
| Merck Sharp & Dohme Corporation | $19.99 | 1 |
| Amgen Inc. | $19.24 | 1 |
| Lilly USA, LLC | $16.86 | 1 |
| Abbott Laboratories | $14.53 | 1 |
| LivaNova USA, Inc. | $13.22 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $229.04 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.53 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124881108 | CMS |
| Amgen Inc. | $19.24 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115491371 | CMS |
| Lilly USA, LLC | $16.86 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135364449 | CMS |
| LivaNova USA, Inc. | $13.22 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152800835 | CMS |
| Merck Sharp & Dohme LLC | $19.99 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141927293 | CMS |
| PFIZER INC. | $13.87 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131537663 | CMS |
| PFIZER INC. | $24.06 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131519514 | CMS |
| Teva Pharmaceuticals USA, Inc. | $28.91 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151584648 | CMS |
| UCB, Inc. | $19.36 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143191635 | CMS |
| UCB, Inc. | $35.36 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143191639 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.64 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144610419 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.